Can Afinitor (everolimus) be reimbursed?

Published: 2011-06-22 06:56:00

Updated: 2011-06-22 06:56:00

Will patients with advanced renal cancer be able to get cheaper and better drugs this year? Now all eyes are on the National Health Insurance Corporation’s decision on the price of Novartis Afinitor (everolimus), the second-line treatment for the disease.

Afinitor is indicated for the treatmen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK